GlassScriptPhysician profile
Charles T Klodell
NPI 1053347468
$102,284.05
in general payments reported to CMS, 2019-2025
16 companies · $8,571 in 2025
The $8,571 reported for 2025 was more than what 88% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,391 · 2020: $23K · 2021: $6,508 · 2022: $36K · 2023: $14K · 2024: $7,580 · 2025: $8,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $7,612 · Consulting Fee: $7,500 · Food and Beverage: $3,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,881.25 |
| Travel and Lodging | $7,612.48 |
| Consulting Fee | $7,500.00 |
| Food and Beverage | $3,841.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $41,967.92 | 2021-2025 | Corevalve Evolut R, Endurant Iis, Apollotm |
| Edwards Lifesciences Corporation | $29,802.51 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Medtronic Vascular, INC. | $24,351.47 | 2019-2020 | |
| Abbott Laboratories | $3,289.16 | 2019-2025 | Triclip, Navitor |
| Boston Scientific Corporation | $1,486.10 | 2019-2023 | |
| Abiomed | $889.91 | 2020-2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $107.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.91 | 2023 | Jardiance |
| Veran Medical Technologies, INC. | $82.23 | 2020 | |
| Zimmer Biomet Holdings, INC. | $67.20 | 2019 | |
| Jenavalve Technology, INC. | $39.88 | 2025 | |
| Philips North America LLC | $39.72 | 2024-2025 | (Ck4) Mcot, Ecc Solutions |
| Novartis Pharmaceuticals Corporation | $23.14 | 2023 | |
| Getinge USA Sales, LLC | $20.53 | 2024 | Vasoview Hemopro 2 |
| Astrazeneca Pharmaceuticals LP | $19.59 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Klodell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.